Arsenic Exposure Linked to Metabolic Disorders Across Generations | Retatrutide News

Paternal in utero arsenic exposure may cause transgenerational metabolic disorders. This could impact research into GLP-1 agonists like Retatrutide.
Clinical Trials · October 14, 2026